These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 5710105)
1. [Side effects of ETA combined with INH and SM in the first antituberculous treatment of pulmonary tuberculosis]. Sosnowski W; Rozniecki J; Kubiak Z; Pruszyńska S Gruzlica; 1968 Oct; 36(10):983-5. PubMed ID: 5710105 [No Abstract] [Full Text] [Related]
2. Severe hypoglycaemia in the course of treatment with streptomycin, isoniazid and ethionamide. Cameron SJ; Crompton GK Tubercle; 1967 Dec; 48(4):307-10. PubMed ID: 5588948 [No Abstract] [Full Text] [Related]
3. [Frequency of side-effects of tuberulostatics and its relation to the applied combination]. Bethge W Z Tuberk Erkr Thoraxorg; 1968; 128(1):258-65. PubMed ID: 4302238 [No Abstract] [Full Text] [Related]
4. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations]. Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752 [No Abstract] [Full Text] [Related]
5. [Critical study of antibiotic tests systematically performed before treatment of pulmonary tuberculous patients]. Benda R; Le Guillou F Sem Ther; 1965 Jan; 41(1):19-21. PubMed ID: 5879027 [No Abstract] [Full Text] [Related]
6. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol. Grymiński J; Lyczewska J; Styszewska H; Walczak J Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841 [No Abstract] [Full Text] [Related]
11. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests]. Pruszyńska S Gruzlica; 1971 Dec; 39(12):1211-8. PubMed ID: 5139240 [No Abstract] [Full Text] [Related]
12. [Association of ethionamide, isoniazid and ethambutol in the therapy of pulmonary tuberculosis]. Zanotelli F Fracastoro; 1967; 60(6):594-607. PubMed ID: 5617704 [No Abstract] [Full Text] [Related]
13. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)]. Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528 [No Abstract] [Full Text] [Related]
14. [Characteristics of drug-induced hepatitis in patients with tuberculosis]. Vil'derman AM Probl Tuberk; 1972; 50(5):59-63. PubMed ID: 4112966 [No Abstract] [Full Text] [Related]
15. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)]. Bleandonu G; Boye J Ann Med Psychol (Paris); 1969 Jul; 2(2):201-26. PubMed ID: 5385334 [No Abstract] [Full Text] [Related]
16. Toxic psychosis to isoniazid and ethionamide in a patient with pulmonary tuberculosis. Sharma GS; Gupta PK; Jain NK; Shanker A; Nanawati V Tubercle; 1979 Sep; 60(3):171-2. PubMed ID: 516171 [No Abstract] [Full Text] [Related]
18. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis]. Rykowska Z Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816 [No Abstract] [Full Text] [Related]
19. [Adverse effect of etiotropic agents in patients with tuberculosis]. Mel'nik VP Vrach Delo; 1991 Jun; (6):89-91. PubMed ID: 1891867 [TBL] [Abstract][Full Text] [Related]
20. [The algodystrophies caused by antituberculous chemotherapy. Study of 24 cases]. Renier JC; Oury M; Bregeon C; Tuchais E Rev Rhum Mal Osteoartic; 1969 Nov; 36(11):605-7. PubMed ID: 5367163 [No Abstract] [Full Text] [Related] [Next] [New Search]